Accolade, Inc.

Transcarent is a generative AI-powered health and care platform that integrates medical, pharmacy, and behavioral health services for employees of self-insured employers and their families. Launched in March 2021, the company operates from offices in Palo Alto, Denver, and Chicago, and is led by CEO Glen Tullman. Transcarent has raised approximately $298 million in funding and recently completed a significant merger with Accolade, expanding its reach to over 20 million members. The flagship offering, the WayFinding™ platform, provides a personalized experience for benefits navigation, clinical guidance, and care delivery. Transcarent offers a comprehensive 24/7 care experience, including primary care, mental health services, pharmacy care, and specialized care for surgery and oncology. The platform is designed for scalability and security, featuring a cloud-native architecture and advanced AI infrastructure. Transcarent aims to simplify healthcare for self-insured employers and their employees, enhancing access and satisfaction in the healthcare experience.